CCA
NITE

Catalyst Capital Advisors’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Catalyst Capital Advisors’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-310
Closed -$6K – 515
2017
Q3 		$6K Buy
+310
New +$6.7K ﹤0.01% 397

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Catalyst Capital Advisors's NITE Position: Q4 2017 in Review

Catalyst Capital Advisors sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2017, closing a stake of 310 shares — an estimated $6K sold.

Catalyst Capital Advisors first reported a position in NITE in Q3 2017 and held it in 1 quarter. The position peaked at $6K in Q3 2017. 16 funds tracked by Wall St. Rank hold NITE as of Q4 2017.

  • Catalyst Capital Advisors reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Catalyst Capital Advisors sold 310 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2017, an estimated $6K.
  • Catalyst Capital Advisors first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 1 quarter.
  • Catalyst Capital Advisors's Nightstar Therapeutics plc American Depositary Shares position peaked at $6K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2017.

Based on Catalyst Capital Advisors's 13F filing for Q4 2017, filed 8 Feb 2018.